Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.
IPO Year: 2015
Exchange: NASDAQ
Website: arcadiabio.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/3/2022 | $7.00 → $6.00 | Buy | HC Wainwright & Co. |
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
10-Q - Arcadia Biosciences, Inc. (0001469443) (Filer)
425 - Arcadia Biosciences, Inc. (0001469443) (Subject)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
425 - Arcadia Biosciences, Inc. (0001469443) (Subject)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
10-K/A - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
10-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
-- Revenues increase 22% year over year driven by 90% growth in Zola® ---- Arcadia sells patents for $750K and eliminates $1M in liabilities ---- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2025. The company has scheduled a conference call at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. "The momentum we experienced in the second half of 2024 has
DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025. The company has scheduled a conference call for 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website.To join the live call, please register
-- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year -- -- Company plans business combination with Roosevelt Resources, Inc. -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024. "We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets," said T.J. Schaefer, president and CEO. "Our focus on Zola® coconut water led to 80 percent revenue growth f
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, pleas
-- Companies to host a joint investor call on December 11, 2024 at 4:30 p.m. ET -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when completed, will combine the two companies in an all-stock transaction. Under the terms of the agreement, Arcadia will issue to the partners of Roosevelt shares of Arcadia common stock at the closing of the transaction in exchange for all of the equity interests in Roosevelt. Following the closing of the transaction, the current equity owners of Roosevelt and the Arcadia shareholders as of the closing are expected to own approximately 90% and 1
– Total revenues increased 18% compared to Q3 2023 – – Zola® coconut water revenues grew 55% year over year – – Zola retail distribution expanded 68% vs. Q3 2023 – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter and first nine months of 2024. "We are extremely pleased with our third-quarter 2024 results, which represent the progress we have made in transforming Arcadia's business as well as our ability to execute on the plan we laid out," said T.J. Schaefer, Arcadia's president and CEO. "Our total revenues increased 18 percent year over y
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2024 after market close on November 12, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please register here, and a dia
-- Company closes $4M transaction with Corteva Agriscience -- -- Above Food Corp acquires GoodWheatTM brand -- -- Zola® coconut water sales increase 42% year over year -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2024. "The second quarter of 2024 was a significant turning point for Arcadia as we transform the business and chart our path to becoming cash flow positive," said T.J. Schaefer, president and CEO. "We monetized our wheat IP through two transactions: selling our resistant starch wheat trait to a wholly ow
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please regist
-- CEO Stan Jacot replaced by CFO Thomas J. Schaefer -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company and been replaced by Thomas J. Schaefer, effective July 5, 2024. Schaefer was previously Arcadia's chief financial officer and will be replaced in that role by Mark Kawakami, Arcadia's current vice president of finance. "On behalf of Arcadia, I would like to thank Stan for his many contributions to the company," said Board of Directors Chairman Kevin Comcowich. "Under his leadership, Arcadia expanded the GoodWheat brand into three categories, sold the brand to
HC Wainwright & Co. reiterated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $6.00 from $7.00 previously
HC Wainwright & Co. reiterated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $7.00 from $6.00 previously
Lake Street initiated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $4.50
HC Wainwright & Co. reiterated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $6.00 from $8.00 previously
-- CEO Stan Jacot replaced by CFO Thomas J. Schaefer -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company and been replaced by Thomas J. Schaefer, effective July 5, 2024. Schaefer was previously Arcadia's chief financial officer and will be replaced in that role by Mark Kawakami, Arcadia's current vice president of finance. "On behalf of Arcadia, I would like to thank Stan for his many contributions to the company," said Board of Directors Chairman Kevin Comcowich. "Under his leadership, Arcadia expanded the GoodWheat brand into three categories, sold the brand to
DAVIS, Calif., Dec. 20, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced it has appointed Kevin Comcowich, current Chairman of the Arcadia Board of Directors, as interim chief executive officer, effective January 1, 2022, as the board of directors finalizes its search for a permanent CEO. As previously announced on September 7, 2021, the board of directors launched a national search for a new CEO as the company further expands into the consumer packaged goods (CPG) sector.
DAVIS, Calif., Nov. 22, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced it has named Brian Schaffer as senior vice president of sales, as the company continues to expand its consumer goods platforms. A seasoned sales and general management executive with deep CPG experience, Schaffer has a proven track record of building and leading world class sales organizations. He is tasked with driving the retail launch of Arcadia's GoodWheat brand, a company priority in 2022 as it w
DAVIS, Calif., Sept. 7, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that it has launched a national search for a new Chief Executive Officer as the company further expands into the consumer packaged goods sector. CEO Matt Plavan will step down from the role once a successor is named, which is expected to occur by the end of the year. Plavan joined Arcadia in 2016 as Chief Financial Officer and has served as Chief Executive Officer since 2019, overseeing the company's
New York, March 04, 2021 (GLOBE NEWSWIRE) -- - Mawson Gold Limited (TSE:MAW) (OTCPINK:MWSNF) (FRA:MXR) encouraged by drill assays from South East Mount Isa project, Australia click here- Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) (FRA:L0MA) supplies its Rapid Emulsion Technology to cannabis-infused beverage manufacturer BevCanna Enterprises click here- NetCents Technology Inc (CSE:NC) (FRA:26N) (OTCQB:NTTCF) sees cryptocurrency transaction volumes top C$6.7M in February click here - FansUnite Entertainment Inc (CSE:FANS) (OTCQB:FUNFF) (FRA:4UY) subsidiaries apply for UK gambling licenses click here - Great Panther Mining Limited (TSE:GPR) (NYSEAMERICAN:GPL) (FRA:
-- Revenues increase 22% year over year driven by 90% growth in Zola® ---- Arcadia sells patents for $750K and eliminates $1M in liabilities ---- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2025. The company has scheduled a conference call at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. "The momentum we experienced in the second half of 2024 has
DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025. The company has scheduled a conference call for 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website.To join the live call, please register
-- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year -- -- Company plans business combination with Roosevelt Resources, Inc. -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024. "We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets," said T.J. Schaefer, president and CEO. "Our focus on Zola® coconut water led to 80 percent revenue growth f
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, pleas
-- Companies to host a joint investor call on December 11, 2024 at 4:30 p.m. ET -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when completed, will combine the two companies in an all-stock transaction. Under the terms of the agreement, Arcadia will issue to the partners of Roosevelt shares of Arcadia common stock at the closing of the transaction in exchange for all of the equity interests in Roosevelt. Following the closing of the transaction, the current equity owners of Roosevelt and the Arcadia shareholders as of the closing are expected to own approximately 90% and 1
– Total revenues increased 18% compared to Q3 2023 – – Zola® coconut water revenues grew 55% year over year – – Zola retail distribution expanded 68% vs. Q3 2023 – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter and first nine months of 2024. "We are extremely pleased with our third-quarter 2024 results, which represent the progress we have made in transforming Arcadia's business as well as our ability to execute on the plan we laid out," said T.J. Schaefer, Arcadia's president and CEO. "Our total revenues increased 18 percent year over y
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2024 after market close on November 12, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please register here, and a dia
-- Company closes $4M transaction with Corteva Agriscience -- -- Above Food Corp acquires GoodWheatTM brand -- -- Zola® coconut water sales increase 42% year over year -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2024. "The second quarter of 2024 was a significant turning point for Arcadia as we transform the business and chart our path to becoming cash flow positive," said T.J. Schaefer, president and CEO. "We monetized our wheat IP through two transactions: selling our resistant starch wheat trait to a wholly ow
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please regist
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will host a call for analysts and investors after market close on May 22, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss recent strategic transactions. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available in the Investors section of Arcadia's website. To join the live call, please register here, and a dial-in number and unique PIN will be provided. Following completion of the cal
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13D/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)